During the past decade, Dr Isabelle Delorme Inc. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dr Isabelle Delorme Inc." #1 sponsor was "Dermira, Inc." with 3 trials, followed by "Innovaderm Research Inc." with 3 trials sponsored, "Amgen" with 1 trials sponsored, "AnaptysBio, Inc." with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dr Isabelle Delorme Inc." #1 collaborator was "Abbott" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Janssen-Ortho LLC" with 1 trials as a collaborator and "Montreal Heart Institute" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Dr Isabelle Delorme Inc." are "Psoriasis" (4 trials), "Plaque Psoriasis" (2 trials), "Atopic Dermatitis" (1 trials), "Atopic Dermatitis Eczema" (1 trials) and "Coronary Atherosclerosis" (1 trials). Many other conditions were trialed in "Dr Isabelle Delorme Inc." in a lesser frequency.

Most popular intervention types in "Dr Isabelle Delorme Inc." are "Drug" (10 trials), "Other" (7 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "DRM02" (3 trials), "Vehicle" (3 trials), "Adalimumab" (1 trials) and "Administration of PUR0110 (Thykamine) 0.05%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr Isabelle Delorme Inc." are 12 trials for "All" genders.

Currently, there are NaN active trials in "Dr Isabelle Delorme Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Dr Isabelle Delorme Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Dr Isabelle Delorme Inc., 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".